0110 GMT - Top Glove Corp.'s earnings outlook seems neutral, Public Investment Bank analyst Thye May Ting says in a note. Projected declines in raw material prices in 1H 2025 may pressure the company to maintain flat or slightly lower pricing to protect market share. However, higher sales volumes, spurred by a potential U.S. tariff hike on Chinese medical gloves due to take effect in January will likely mitigate some of that pressure, she says. Top Glove's production capacity is on track to increase 6.7% to 64 billion pieces annually, she adds. Public IB maintains a neutral rating on Top Glove with a MYR1.20 target. Shares are 3.0% higher at MYR1.36. (yingxian.wong@wsj.com)
(END) Dow Jones Newswires
December 22, 2024 20:13 ET (01:13 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。